Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32033 total
Five executives at IRDM filed sales this week totalling nearly $19M. The COO, Chief Legal Officer, Chief Accounting Officer, and two directors all dumped shares at around $50 each on August 17. Filings landed on August…
Short sellers are making fresh bets across several high-profile names. Data as of August 20 shows clear movers worth watching. RDDT is the week's biggest social-media mover on the short side. SI jumped 4.1 percentage…
The biggest story this week is simple: money is flowing into the US at scale. ETF investors poured a net $39.2B into US-focused funds in the past seven days. The flow imbalance score hit 71.3, signalling strong buying…
The US bond market is dominating sentiment. The 30-year Treasury yield rose again Thursday after Treasury Secretary Bessent's move to boost long-term debt buybacks failed to calm investors. Wall Street called it a…
Citigroup made a bold call on MRVL Thursday. Analyst Atif Malik raised his price target to $275 from $225 — a 22% jump. Marvell carries a $220 billion market cap. Short interest sits at just 4.6% of free float. The AI…
Bill Gates has been quietly loading up on RSG. Filings published this week show he spent over $170M buying Republic Services shares across five separate transactions between August 13–18. The waste management giant…
Short sellers are on the move. ORTEX data dated August 20 shows several notable jumps in short interest over the past week. RDDT saw the biggest increase among large-caps. Short interest as a % of free float jumped to…
Citigroup downgraded WB to Neutral on Thursday. The move came with a 16% price target cut — from $9.30 to $7.80. That target sits just 8% above Wednesday's close of $7.19. The stock has lost 10% over the past…
Two safe-haven trades dominated Friday's headlines. Gold broke above $4,600 an ounce. It is up more than 14% in August alone — its best monthly gain since 1999. The metal trades above every key moving average. At the…
Salesforce headlines a packed earnings schedule this week. The CRM giant reports Q2 2027 results on Wednesday, August 26. Analysts are watching for AI-driven revenue growth signals. Also Wednesday, HP Inc. reports Q3…
JP Morgan analyst Jessica Fye raised her price target on MRNA to $77 from $40 — a 93% jump. The stock stays rated Sell. That gap between a rising target and a bearish rating is unusual. Short interest sits at 13.3% of…
JP Morgan made a bold call on MRNA Thursday. Analyst Jessica Fye nearly doubled her price target — from $40 to $77. She kept a Sell rating. That gap between a bullish target and a bearish rating signals a complex view…
The past two weeks saw a wave of significant insider selling across US-listed stocks. Filings reveal coordinated exits at several companies. The most striking pattern is at AEHR. Six insiders — including CEO Gayn…
Short sellers are moving fast. RDDT saw the biggest 7-day jump among large US stocks. Its SI % of FF rose 4.1 points to 17.6% in one week. Bears are betting hard against the social platform even as retail investors…
Short sellers turned up the heat on RDDT this week. Short interest jumped to 17.6% of free float, up from 13.5% just seven days ago — a 4.1 percentage point swing. That's the biggest 7-day SI move among mid-to-large US…
U.S.-focused ETFs pulled in $51B in the past week. That dwarfs every other geography. Over three months, the lead grows to $382B — confirming America remains the default destination for institutional capital. The…
Keefe, Bruyette & Woods just made the boldest call on Progressive in weeks. The firm upgraded the insurer to Outperform and lifted its price target 10.6% to $250. The stock closed at $220.34 on Thursday — implying…
Allstate has shed nearly a quarter of its short interest in the past week. Now a second analyst firm has piled on with a downgrade — even as the bears are leaving. Keefe, Bruyette & Woods downgraded ALL to Underperform…
Analog Devices triggered a wave of analyst action on August 20. At least eight firms revised their views post-earnings. The stock sits at $370.24 — well below a consensus target that has moved sharply…
Citigroup downgraded TJX to Neutral on Thursday, slashing its price target 15% to $154. That implies 9% downside from Wednesday's close of $140.69 — a sharp reversal from Citi analyst Paul Lejuez's prior Buy rating…
